1. Home
  2. BEAM vs SBLK Comparison

BEAM vs SBLK Comparison

Compare BEAM & SBLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • SBLK
  • Stock Information
  • Founded
  • BEAM 2017
  • SBLK 2006
  • Country
  • BEAM United States
  • SBLK Greece
  • Employees
  • BEAM N/A
  • SBLK N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • SBLK Marine Transportation
  • Sector
  • BEAM Health Care
  • SBLK Consumer Discretionary
  • Exchange
  • BEAM Nasdaq
  • SBLK Nasdaq
  • Market Cap
  • BEAM 2.3B
  • SBLK 1.9B
  • IPO Year
  • BEAM 2020
  • SBLK N/A
  • Fundamental
  • Price
  • BEAM $22.21
  • SBLK $15.98
  • Analyst Decision
  • BEAM Strong Buy
  • SBLK Strong Buy
  • Analyst Count
  • BEAM 11
  • SBLK 3
  • Target Price
  • BEAM $50.50
  • SBLK $22.67
  • AVG Volume (30 Days)
  • BEAM 2.3M
  • SBLK 2.3M
  • Earning Date
  • BEAM 05-06-2025
  • SBLK 05-21-2025
  • Dividend Yield
  • BEAM N/A
  • SBLK 13.39%
  • EPS Growth
  • BEAM N/A
  • SBLK 60.00
  • EPS
  • BEAM N/A
  • SBLK 2.80
  • Revenue
  • BEAM $63,518,000.00
  • SBLK $1,265,458,000.00
  • Revenue This Year
  • BEAM N/A
  • SBLK N/A
  • Revenue Next Year
  • BEAM $6.32
  • SBLK $18.23
  • P/E Ratio
  • BEAM N/A
  • SBLK $5.71
  • Revenue Growth
  • BEAM N/A
  • SBLK 33.31
  • 52 Week Low
  • BEAM $20.84
  • SBLK $14.30
  • 52 Week High
  • BEAM $35.25
  • SBLK $27.47
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 38.64
  • SBLK 48.24
  • Support Level
  • BEAM $21.60
  • SBLK $16.38
  • Resistance Level
  • BEAM $24.53
  • SBLK $17.34
  • Average True Range (ATR)
  • BEAM 1.64
  • SBLK 0.47
  • MACD
  • BEAM -0.24
  • SBLK -0.08
  • Stochastic Oscillator
  • BEAM 8.85
  • SBLK 37.04

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About SBLK Star Bulk Carriers Corp.

Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.

Share on Social Networks: